Compare BIOA & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIOA | MVBF |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.0M | 390.6M |
| IPO Year | 2024 | 2004 |
| Metric | BIOA | MVBF |
|---|---|---|
| Price | $7.11 | $29.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $51.50 | $29.50 |
| AVG Volume (30 Days) | ★ 621.6K | 37.0K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | ★ 66.21 | 34.64 |
| EPS | N/A | ★ 1.32 |
| Revenue | ★ $8,995,000.00 | $3,400,000.00 |
| Revenue This Year | $720.93 | $1.70 |
| Revenue Next Year | N/A | $13.59 |
| P/E Ratio | ★ N/A | $22.48 |
| Revenue Growth | N/A | ★ 51.92 |
| 52 Week Low | $5.05 | $23.99 |
| 52 Week High | $25.96 | $31.99 |
| Indicator | BIOA | MVBF |
|---|---|---|
| Relative Strength Index (RSI) | 28.10 | 39.72 |
| Support Level | N/A | $29.34 |
| Resistance Level | $8.53 | $30.22 |
| Average True Range (ATR) | 0.48 | 0.70 |
| MACD | 0.10 | -0.18 |
| Stochastic Oscillator | 7.11 | 8.98 |
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
MVB Financial Corp is a financial holding company. The company provides a wide range of business activities through the Bank, commercial and retail banking services, as well as Fintech banking. It has three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of its revenue is generated from the CoRe Banking segment, which includes its Fintech division, represents banking products and services offered to customers by the Bank, loans and deposits accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.